Why One Drug Company Held Back a Better Drug
Drug companies say patents spur innovation. Can they also do [...]
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it [...]
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEP
A jury sided with Gilead Sciences in a dispute over [...]
F.D.A. Approves Remdesivir for Patients Not Hospitalized
The treatment must be given via intravenous infusion over three [...]